Nanocarriers based on bacterial membrane materials for cancer vaccine delivery
Top Cited Papers
Open Access
- 25 July 2022
- journal article
- research article
- Published by Springer Nature in Nature Protocols
- Vol. 17 (10) , 2240-2274
Abstract
Here we present a protocol for the construction and use of two types of nanocarrier based on bacterial membrane materials for cancer vaccine delivery. Cancer vaccines induce tumor regression through triggering the specific T-cell responses against tumor neoantigens, a process that can be enhanced by nanocarrier delivery. Inspired by the body’s natural immune defenses against bacterial invasion, we have developed two different types of nanocarrier based on bacterial membrane materials, which employ genetically engineered outer-membrane vesicles (OMVs), or hybrid membrane vesicles containing bacterial cytoplasmic membrane, respectively. The OMV-based nanocarriers can rapidly display different tumor antigens through the surface modified Plug-and-Display system, suitable for customized cancer vaccines when the tumor neoantigens can be identified. The hybrid membrane-based nanocarriers are prepared through fusion of the bacterial cytoplasmic membrane and the primary tumor cell membrane from surgically removed tumor tissues, possessing unique advantages as personalized cancer vaccines when the neoantigens are not readily available. Compared with chemically synthesized nanocarriers such as liposomes and polymer without intrinsic adjuvant properties, owing to the large amounts of pathogen-associated molecular patterns, the two nanocarriers can activate the antigen-presenting cells while delivering multiple antigens, thus inducing effective antigen presentation and robust adaptive immune activation. Excluding bacterial culture and tumor tissue collection, the preparation of OMV- and hybrid membrane-based nanocarriers takes ~8 h and 10 h for tumor vaccine construction, respectively. We also detail how to use these nanocarriers to create cancer nanovaccines and evaluate their immunostimulatory and antitumor effects.Keywords
This publication has 54 references indexed in Scilit:
- Immune modulation by bacterial outer membrane vesiclesNature Reviews Immunology, 2015
- Detoxifying Escherichia coli for endotoxin-free production of recombinant proteinsMicrobial Cell Factories, 2015
- Neoantigens in cancer immunotherapyScience, 2015
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencingNature, 2014
- Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug DeliveryNano Letters, 2014
- Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinomaBMC Genomics, 2014
- Signatures of mutational processes in human cancerNature, 2013
- Immunotherapy with autologous tumor cell vaccines for treatment of occult disease in early stage colon cancerHuman Vaccines & Immunotherapeutics, 2012
- The Bacterial Cell EnvelopeCold Spring Harbor Perspectives in Biology, 2010
- The structure of a cytolytic α-helical toxin pore reveals its assembly mechanismNature, 2009